Visit the Aurora Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Aurora Cannabis Exceeds 3,000 Active Registered Patients in Five Months
Production, Inventory and Customer Care Meeting Rising Demand
VANCOUVER, BRITISH COLUMBIA–(Marketwired – May 30, 2016) – Aurora Cannabis Inc. (cse:ACB)(frankfurt:21P)(wkn:A1C4WM)(otcqb:ACBFF) (“Aurora” or the “Company”), announced that the Company has exceeded 3,000 active registered patients over the first five months since commencement of product sales on January 5, 2016. Management believes this is the fastest organic rate of growth in patient registration that any Licensed Producer has achieved, and will help the Company towards reaching profitability in record time.
The Company previously announced on March 31, 2016 that it had registered 1,000 patients in its first three months of product sales, and on May 9, 2016 that it had surpassed 2,000 patients over its first four months of sales.
Aurora’s pace of patient acquisition is unprecedented in the industry, and has exceeded our expectations. We had optimistically planned for this high rate of growth, and I’m proud that our cannabis production and inventory, as well as our customer care team, continue to manage this increasing demand very well.
Terry Booth, CEO
Our customer retention rate thus far exceeds 90%, and we will continue to be diligent in ensuring that we onboard patients at a pace we can accommodate as we continue to scale up. At the same time, we will ensure our patients remain completely satisfied with Aurora’s medical cannabis and their overall customer care experience is aligned with the Aurora Standard.
Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the Canadian Securities Exchange under the symbol “ACB”.
On behalf of the Board of Directors,
AURORA CANNABIS INC.
Terry Booth, CEO
The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.
Aurora Cannabis Inc.
Senior Vice President
The most reliable, fact-based information on Aurora Cannabis found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.